Écrit par GlobalData | 25 Juin 2012

LONDON, UK (GlobalData), 25 June 2012 - The in-vitro diagnostic industry is witnessing companion diagnostics emerge as the next big thing, as attention in the pharmaceutical industry shifts from blockbuster drugs to personalized medical treatment, says a new report by healthcare experts GlobalData.

The new report* states that the companion diagnostics industry is being spurred on as the...

Écrit par GBI research | 21 Juin 2012

NEW YORK (GBI Research), 21 June 2012 - Argentina is boosting the health of their citizens thanks to strong government schemes that are providing medical attention to those that need it, while financially supporting the country’s in-house pharmaceutical production, according to a new report from healthcare experts GBI Research.

The new report shows that the Argentine pharmaceutical market...

Écrit par GlobalData | 20 Juin 2012

LONDON, UK (GlobalData), 20 June 2012 - European healthcare is being transformed as a result of economic recession, as austerity measures reshape the way that countries run, states a new report by healthcare experts GlobalData.

The new report* looks at the sovereign debt crisis, formed by a collection of budget deficits created by insufficient tax revenue and excessive spending in across...

Écrit par Pluristem Therapeutics | 19 Juin 2012

HAIFA, ISRAEL – June 19, 2012 -- Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE: PLTR) announced today at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for...